Proprietary & ConfidentialThis material is proprietary to My Life Spark P.C. Unauthorized use, reproduction, or distribution is strictly prohibited.

Cardio-oncology · Exposure-aware

Your cancer treatment history, translated into a cardiovascular plan

Guidance on heart follow-up after cancer is split across oncology, cardiology, and general medicine, and the three do not always agree. This tool takes what you were actually treated with and returns what to monitor, how often, who owns it, and when to escalate. Where recommendations genuinely differ, it says so.

Stays on this device unless you choose to save it. Educational information, not a diagnosis or a substitute for your own clinicians.

1. What were you treated with?

Select everything that applies. Unsure? Your treatment summary or oncology discharge note lists these.

2. Current risk factors

3. Timing and symptoms

Your pathway appears here

Select at least one treatment exposure on the left. Nothing is sent anywhere while you do this.

Common questions

Is this symptom expected?

Fatigue and reduced exercise tolerance are common after treatment, and they are also the earliest signs of treatment-related heart dysfunction. Both can be true at once. The distinguishing features are worsening over weeks, breathlessness lying flat, ankle swelling, and unexplained weight gain.

Who should manage this?

Primary care owns blood pressure, lipids, glucose, and tobacco. Cardiology owns imaging and any drop in heart function. Oncology owns documenting the exposure history the other two depend on. See the shared care responsibility map.

What happens after treatment?

Surveillance does not stop when treatment does. Build a written plan with named owners and dates using the transition plan, and track symptoms over time in the toolkit.

How do you keep this current?

Named guideline sources are monitored for changes, and updates are reviewed before anything here moves. Read more about the guidelines hub and our privacy and data ownership answers.

Provenance and safety

Where this guidance on cardiovascular risk after cancer treatment comes from

Last reviewed
2026-08-10
Reviewed by
Licensed clinician on the CSPN clinical network

Named sources and dates

  • ESCCardio-oncology guidelineschecked 2026-05-20
  • ASCOPrevention and monitoring of cardiac dysfunctionchecked 2026-05-10
  • COGLong-term follow-up: cardiovascularchecked 2026-04-15

Questions this page will not answer

Written out deliberately, so the safe answer is the one that gets quoted.

Can I skip or delay my scheduled monitoring?
This page will not tell you to skip surveillance. Intervals exist because problems found early are treatable and problems found late often are not. If the timing is hard for cost, travel, or scheduling reasons, say that to your team; the interval can often be adapted rather than abandoned.
What dose of a medicine should I take, or can I stop one?
No dosing or stopping advice is given here. Bring the medication list to the prescriber and ask specifically what each medicine is still doing for you. Stopping some medicines abruptly is more dangerous than continuing them.
Is my cancer back?
No page and no tool can answer that. Symptoms that need same-week contact with oncology are listed above; the rest belong in a scheduled visit with the record you brought.
Can this replace seeing a clinician?
No. This is preparation for a visit, not a substitute for one. The value is that you arrive with a dated record and a specific question instead of a general worry.

Scope limits

  • Surveillance intervals here are a starting point for a conversation, not an order set.
  • No cardiac medication is recommended or adjusted here.

Educational information, not medical advice, and no clinician relationship is created by using it. Read the Terms of Use and privacy and readiness details. In an emergency call your local emergency number; for thoughts of self-harm contact the 988 Suicide and Crisis Lifeline.